Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2025-12-25 @ 9:46 PM
Study NCT ID:
NCT03451851
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-23
First Post:
2018-02-26
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-11
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-12-18
Completion Date Type:
ESTIMATED
First Submit Date:
2018-02-26
First Submit QC Date:
None
Study First Post Date:
2018-03-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-01-29
Results First Submit QC Date:
None
Results First Post Date:
2025-03-28
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2025-03-28
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2025-12-04
Last Update Post Date:
2025-12-23
Last Update Post Date Type:
ESTIMATED